Reportedly, 3M (MMM) has completed the acquisition of Acelity, Inc., a leading global medical technology and its worldwide KCI subsidiaries for a total enterprise value of approximately $6.7 billion inclusive of debt and other adjustments. The deal was advised by Apax Partners along with controlled and regulated affiliates of the Public Sector Pension Investment Board and Canada Pension Plan Investment Board.
“This is an exciting day as we bring together two premier and innovative companies that are focused on delivering comprehensive health care solutions to enable better outcomes for patients,” stated 3M chairman and CEO Mike Roman.
3M’s Medical Solutions business applies 3M technologies and offers safe and effective solutions to improve clinical outcomes and the healthcare industry through its solutions that include advanced and acute wound care dressings, medical tapes, sterilization needs, and others. The Acelity business aims to work for unexplored clinical needs with KCI-branded products that advance the practice of medicine with the innovation of V.A.C.® Therapy – groundbreaking Negative Pressure Wound Therapy. The transaction to be further discussed by 3M on the third-quarter earnings call on October 24th, 2019.
3M (MMM) is a global science company that seems to never stop inventing. Using 46 technology platforms, their integrated team of scientists and researchers works with customers to create breakthroughs. Their inventions have improved daily life for hundreds of millions of people all over the world. With $30 billion in sales, 90,000 employees connect with customers all around the world. Scientists, researchers, and marketers work across countries and across subjects to solve challenges big and small. To learn more about 3M (MMM) and to track its ongoing progress please visit the Vista Partners 3M (MMM), Coverage Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.